Clinical Trial Update: Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial of zanzalintinib for advanced urothelial carcinoma progressing after prior therapy is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: Guru Sonpavde | Conditions: Advanced Urothelial Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING